menu search

Myriad genetics' (mygn) new pact to use mrd testing platform

Myriad Genetics (MYGN) announces research collaboration with MD Anderson on metastatic RCC with its high-definition MRD research testing platform base...

June 13, 2023, 9:17 am

Intellia therapeutics announces new positive clinical data from phase 1 study of ntla-2002, an investigational in vivo crispr genome editing treatment for hereditary angioedema (hae)

Extended Phase 1 data reinforce the potential of NTLA-2002 to be a functional cure for people living with hereditary angioedema (HAE) Across all patie...

June 11, 2023, 12:30 pm

Prophase labs continues to make the right moves - reiterate strong buy

ProPhase Labs thrived in the Covid era and then wisely used the gains to invest in new testing capabilities including whole ...

June 11, 2023, 1:16 am

Is invesco dynamic biotechnology & genome etf (pbe) a strong etf right now?

Launched on 06/23/2005, the Invesco Dynamic Biotechnology & genome ETF (PBE) is a smart beta exchange t...

June 7, 2023, 7:33 am

Caribou biosciences to participate in upcoming investor conferences

BERKELEY, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR ...

May 31, 2023, 4:00 pm

Intellia therapeutics to present updated interim data from ongoing phase 1/2 study of ntla-2002 for the treatment of hereditary angioedema (hae) at the eaaci hybrid congress 2023

Late-breaking presentation will include new safety, kallikrein reduction and attack rate data across all dose cohorts in the Phase 1 portion of the st...

May 31, 2023, 11:30 am

Oxford nanopore technologies hails advances

Oxford Nanopore Technologies PLC (LSE:ONT) has announced significant breakthroughs in its nanopore sequencing technology at the annual London Calling...

May 19, 2023, 3:02 am

Editas medicine to present clinical data from the ruby trial of edit-301 for the treatment of severe sickle cell disease at the eha 2023 congress

Company-sponsored webinar to be announced CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical stage <...

May 11, 2023, 2:32 pm

Editas medicine to present clinical data from the ruby trial of edit-301 for the treatment of severe sickle cell disease at the eha 2023 congress

CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical stage gen...

May 11, 2023, 10:32 am

Caribou biosciences announces appointment of stephen j. schuster, md, to its scientific advisory board

— Dr. Schuster is a world-renowned hematologist and pioneer in CAR-T cell therapy development — BERKELEY, Calif., May 08, 2023 (GLOBE NEWSWIRE) �...

May 8, 2023, 1:00 pm

Should you invest in the invesco dynamic biotechnology & genome etf (pbe)?

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the Invesco Dynamic Biotechnolog...

May 3, 2023, 7:39 am

Caribou biosciences to participate in upcoming investor conferences

BERKELEY, Calif., May 01, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR ...

May 1, 2023, 4:00 pm

Intellia therapeutics releases 2023 corporate responsibility report highlighting the advancement of its environmental, social & governance (esg) priorities

CAMBRIDGE, Mass., May 01, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage ...

May 1, 2023, 11:30 am

Vor bio to participate in upcoming investor conferences

CAMBRIDGE, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome...

April 18, 2023, 8:00 am

Bionano genomics: dilution coming

Today, we circle back on an interesting diagnostic concern called Bionano Genomics, Inc. The company continues to build out its promising optical ...

April 13, 2023, 1:15 pm

Vor bio announces q4 and fy 2022 results

Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, reported its financial res...

March 24, 2023, 2:08 pm

Pacbio's (pacb) latest offering to enhance genome analysis

PacBio's (PACB) new informatics analysis method, Paraphase, will enable researchers to genotype gene paralogs and pseudogenes with high accuracy....

March 15, 2023, 12:14 pm

Is bionano genomics stock a buy now?

Bionano Genomics is rapidly rolling out its genome mapping device. Its competitors don't have any produ...

March 7, 2023, 9:45 am

Should you invest in the invesco dynamic biotechnology & genome etf (pbe)?

Sector ETF report for PBE...

February 27, 2023, 7:32 am


Search within

Pages Search Results: